Pharma Warns On O'Neill Levy Idea But Wants To Join Global AMR Fight

 
• By Sten Stovall

The drugs industry has slammed the O'Neill AMR Review's proposal that pharma pays for a big part of the bill for tackling antimicrobial resistance – warning it could delay a solution and illustrating how difficult it might be to forge the collective worldwide response that the report calls for.

Pills and money
Who Will Pay For Needed New Antibiotics? • Source: Shutterstock

More from Strategy

More from Business